Navigation Links
Safe in Common Offers Experienced Advice for U.K.'s Review of Needlestick Safety Regulations

NEW YORK, Sept. 6, 2012 /PRNewswire/ -- Safe in Common (SIC) today encouraged the United Kingdom Health and Safety Executive (HSE) to build on the lessons learned in the United States as it reviews the development of national laws designed to protect healthcare personnel from needlestick injuries.

Safe in Common is a non-profit organization dedicated to protecting 5.6 million U.S. healthcare workers at risk of needlestick injury.  The Chairperson of Safe in Common, Dr. Mary Foley, has been active in the American Nurses Association since 1994 and was President from 2000-2002.  She played a key role in the adoption of several state initiatives to reduce injuries to healthcare workers and worked at the national level to secure passage of the Federal Needlestick Safety and Prevention Act in 2000.

Dr. Foley welcomed the start of a six month review by HSE, which comes in response to an E.U. directive adopted in 2010 that requires all European member states to implement national laws for needlestick prevention by May 2013. These laws will seek to mandate the use of safety-engineered devices and other procedures to protect those at risk of infection with blood-borne pathogens such as HIV from needlestick and sharp object injuries. The E.U. Commission for Employment has estimated that needlestick injuries are one of the most serious health and safety threats in European workplaces, and the cause of approximately one million injuries each year.

Dr. Foley said: "It is promising that E.U. countries including the U.K. are seeking feedback from industry leaders regarding the development of the most effective national legislation to protect healthcare workers at risk of harm. We believe it's wise for them to pay close attention to what's transpired in the U.S. over the last decade since we began to mandate and enforce the use of safety products in healthcare facilities."

"The majority of U.S. acute-care facilities have now largely converted to the use of safety engineered medical devices.  This has helped to reduce overall rates of reported needlestick injuries by around one-third. Yet we must still address a number of outstanding challenges regarding compliance, enforcement and selection of the safest, simplest medical products. As a result, we are now playing catch-up. I think this is a great opportunity for the U.K. and European countries to learn from our mistakes and to get it right the first time."

As the U.K. continues to review the Directive, SIC offered advice on how to set needlestick regulations:

  • Require all healthcare facilities to select the safest, simplest devices for every procedure regardless of cost. Devices with automatic (passive) and fully integrated safety features have in particular been found to minimize the risk of occupational exposures. Where such devices are available and compliant with the procedures of the facility, they must be required for use regardless of upfront cost.
  • All healthcare facilities should be inspected at least every two years by occupational healthcare safety authorities to ensure they are fully compliant with needlestick prevention laws, with strict penalties in place to discourage non-compliance.
  • Device manufacturers should be required to give full training within each facility where their safety products are being adopted, and on regular periods afterwards, to ensure healthcare personnel are using them correctly.  The healthcare facility should also train expert users who can assist in ongoing educational efforts.
  • After the introduction of new devices, it is recommended that close attention be made to the trends in injuries.  Some devices may take a short period of use before becoming familiar to staff.  Other devices, although promoted as safety devices, may introduce new types of injuries.  Careful evaluation of those trends is important especially in the first few months of adoption.
  • All occupational exposures, including needlestick injuries and other sharp object injuries need to be reported in a logbook that captures key information including user occupation, type of device involved, whether a safety mechanism was available and correctly engaged and at what stage of a procedure the accident occurred. This data should be collated by government occupational health and safety authorities and published on an annual basis.  Frontline staff must have immediate access to that data.
  • Each hospital must be required to take into account the level of needlestick safety features provided in drugs and vaccines supplied by pharmaceutical companies in a prefilled syringe format. Facilities should demand those products be supplied with safety devices.
  • The E.U. should develop and aggressively promote a national database on available safety engineered medical devices.

Dr. Foley also encouraged the U.K. and other European agencies to consider the expansion of legislation and regulations to protect those at risk of needlestick injuries outside of healthcare facilities.

On behalf of Safe in Common, Dr. Foley sent an open invitation to all E.U.-based healthcare leaders to lean on Safe in Common as a resource, participate in SIC's on-going dialogue regarding eradicating needlestick injuries, and sign the Needlestick Safety Pledge.

For more information about Safe in Common or to learn about partnership opportunities and the Organization's ongoing work to promote utilizing safer engineering controls that protect healthcare workers from unnecessary needlestick and sharps related injuries, please visit

About Safe in Common
Safe in Common is a non-profit organization established to enhance and save the lives of U.S. healthcare personnel at risk of harm from needlesticks and sharps injuries.  It is led by Chairperson Mary Foley, PhD, RN, former President of the American Nurses Association and other industry leaders. To learn more about the Needlestick Safety Pledge and its goal of promoting and strengthening the Federal Needlestick Safety and Prevention Act, go to and follow Safe in Common on Twitter at

Media Contacts:
Joe McGurk
KCSA Strategic Communications

SOURCE Safe in Common
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. MAP Pharmaceuticals, Inc. Announces Full Exercise of Underwriters Option to Purchase Additional Shares of Common Stock
2. Solta Medical, Inc. Closes Public Offering of Common Stock
3. K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC Markets
4. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
5. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
6. MAP Pharmaceuticals, Inc. Prices Public Offering of Common Stock
7. Cell Therapeutics Announces Institutional Investor Purchased Additional $15 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
8. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
9. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
10. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
11. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
Post Your Comments:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... Dehaier Medical Systems Ltd. (NASDAQ: DHRM ) ... medical devices and wearable sleep respiratory products in ... with Hongyuan Supply Chain Management Co., Ltd. (hereinafter referred ... to develop Dehaier,s new Internet medical technology business. ... Hongyuan Supply Chain,s sales platform to reach Dehaier,s dealers ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):